1 / 9

Why Project ECHO? Prescription Drug Abuse and Misuse in Delaware

nevin
Download Presentation

Why Project ECHO? Prescription Drug Abuse and Misuse in Delaware

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Delaware Telehealth ConferenceProject ECHO Update(Extension for Community Health Care Outcomes) March 25, 2014Meeting the Challenge of Pain Management and Opioid Addiction in Primary CareUsing Videoconferencing to Link Specialists and Primary Care Health ProvidersPresentation By: J. Kevin Massey Delaware, Division of Public HealthPrescription Drug Action CommitteeCo-ChairsKaryl Rattay, MD, MS, Director, Delaware Division of Public HealthRandeep Kahlon, MD, Past President of the Medical Society of Delaware

  2. Why Project ECHO? Prescription Drug Abuse and Misuse in Delaware • Delaware: 9th highest drug overdose death rate (2009) • DE average deaths per 100,000 population: 12.6 • National average deaths per 100,000: 12.0 • Drug overdose death rate increased 142% (1999-2009) • More Delaware residents 12 and older report using non-medical use of opioid pain relievers • DE average: 5.6% • National average: 4.8% • Substance abuse treatment admission rates for opioids increased over 2,750% (1999-2010) • Delaware 5th highest for opioid sales (2010) • DE average: 10.2 KG per 100,000 population • National average: 7.1 KG per 100,000 population

  3. Why Project ECHO? A Coordinated Team Approach to Action – The Prescription Drug Action Committee, PDAC • History • Established in February 2012. • Focused on coordinating public, private and community efforts under the leadership of the Division of Public Health and the Medical Society of Delaware. • The PDAC has a broad and diverse membership. • To date, has conducted 18 full committee public meetings and over 50 sub committee meetings. • The PDAC has developed a comprehensive set of recommendations to combat drug abuse, misuse and diversion statewide. Implementation of these recommendations is ongoing. • You can access our PDAC report on our website address: http://dhss.delaware.gov/dhss/dph/pdachome.html

  4. PDAC Leadership – Co-Chairs & Sub-Committee Chairs • PDAC Co-Chairs • Karyl Rattay, MD, MS, Director of Delaware Division of Public Health • Randeep Kahlon, MD, Past President of the Medical Society of Delaware • Staff Support:J. Kevin Massey, Delaware, Division of Public Health • Next public meeting is on Monday, April 28, 2014 at the Medical Society of Delaware. PDAC Sub-Committee Chairs (A.C.E) • Access to Treatment: Marc Richman, PhD Assistant Director for Delaware Substance Abuse & Mental Health • Control: John Goodill, MD Delaware Pain Initiative • Education: Sandra Retzky, MD., RPh., MPH, MBA Healthcare Fellow Office of US Senator Christopher A. Coons

  5. Project ECHO – Expanding Access to Treatment and Education “The mission of Project ECHO (Extension for Community Health Care Outcomes) is to develop the capacity to safely and effectively treat chronic, common and complex diseases in rural and underserved areas and to monitor outcomes.” Dr. Sanjeev Arora, University of New Mexico – Founder, Project ECHO. • HEALTHCARE DILEMMA • How can a specialist better manage thousands of patients who live a long distance from his or her office? • How can specialty care reach underserved populations? • How can this be accomplished without adding to the workforce? • How can this be accomplished with the existing infrastructure? • CONCLUSIONS AND OUTCOMES • Replicated world wide i.e. Department of Defense; Harvard Medical Center; India, New Delhi, The Community Healthcare Center, Inc., Veterans Administration, etc. • Proven to significantly increase knowledge, skills and abilities. Leads to improved patient experience and outcomes. • Reduces cost of care

  6. Goals and Methods of Delaware Project ECHO Goals • Develop the capacity to safely and effectively treat related opioid and addiction diseases in all areas in Delaware and monitor outcomes • Develop a model to safely treat complex diseases especially in rural locations in the state. Methods • Use cost effective technology (Vidyo videoconferencing) to leverage scarce healthcare resources. • Disease management model focus on improving outcomes by reducing variation in processes of care and sharing best practices. • Cased based and interactive learning between specialists and primary care providers. Benefits to Clinicians • No cost CME’s and CEUs • Professional interaction with colleagues with similar interests i.e. physicians, nurse practioners, physician assistants, etc. • A mix of work and learning. • Access to specialty consultation in pain management and medication assisted treatment i.e. Buprenorphine. Others are available.

  7. Delaware Project ECHO Steps for Pain Management and Opioid Addiction Treatment Education • 2 hour weekly or bi monthly sessions, depending upon the topic • Case submission form • Expert specialty team located anywhere in the world • Local Delaware and Remote Project ECHO manager • 15-20 minute didactic presentation • Deidentified case presentation (2-10) • Primary care providers can join from anywhere in the world using a desktop or mobile device. No expensive hardware or software. Ease set up. • Access to a dedicated Project ECHO secure website to reference materials

  8. Disease Selection in Delaware: Pain Management and Opioid Addiction Treatment • Management is complex • Evolving treatments and medicines • High societal impact (health and economic) • Serious outcomes of untreated disease • Improved outcomes with disease management • Other commons diseases are available. Potential Benefits of ECHO model to Health System • Quality and safety • Rapid learning and best practice dissemination • Expand access to care and reduce variations in care • Improve professional satisfaction/retention • Cost effective care (avoid excessive testing and travel) • Supports the Medical Home Model Current Delaware ECHO Projects and Participants • Westside Family Healthcare – Pain Management • University of Delaware, Nurse Managed Health Center – Pain Management, Summer 2014 • Brandywine Counseling – Buprenorphine, Medication Assisted Treatment • Connections – Buprenorphine, Medication Assisted Treatment • Horizon House – Buprenorphine, Medication Assisted Treatment • Kent Sussex Counseling Services – Buprenorphine, Medication Assisted Treatment • Thresholds, Inc. – Buprenorphine, Medication Assisted Treatment Delaware Executive Sponsors and Education Partners • The Community Health Center, Inc. of Connecticut (FQHC) • The State of Delaware, Department of Health and Social Services • The Delaware Telehealth Coalition • The Prescription Drug Action Committee (PDAC)

  9. Contact Me: Jonathan Kevin Massey Jonathan.massey@state.de.us 302.744.4919 PDAC http://dhss.delaware.gov/dhss/dph/pdachome.html

More Related